Late small bowel toxicity after aggressive abdominopelvic intensity modulated radiation therapy
Purpose: We retrospectively analyzed late small bowel toxicity in patients who received abdominal or pelvic intensity modulated radiation therapy (IMRT) to the small bowel with a maximum dose greater than the generally accepted maximal tolerable dose of 45 Gy. Methods and materials: All patients (N ...
Main Authors: | Andrew Ling, BA, Eli Furhang, PhD, DABMP, Shannon N. Ryemon, MS, Ronald D. Ennis, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-10-01
|
Series: | Advances in Radiation Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452109417301914 |
Similar Items
-
Body composition determinants of radiation dose during abdominopelvic CT
by: Patrick D. McLaughlin, et al.
Published: (2017-10-01) -
Thoracic and abdominopelvic actinomycosis
by: K Spiegel, et al.
Published: (2005-04-01) -
Whole abdominopelvic intensity-modulated radiation therapy for peritoneal disseminated rhabdomyosarcoma with three-year follow-up: a case report
by: Mariko Kawamura, et al.
Published: (2019-07-01) -
Abdominopelvic Actinomycosis Mimicking Ovarian Cancer
by: Wei-Min Hu, et al.
Published: (2005-12-01) -
Surgical outcomes of adult patients with abdominopelvic sarcomas
by: J.Y. Baik, et al.
Published: (2020-07-01)